COMPLETE CONTROL System Gen2

by Coapt  · Based in United States → — Complete Prosthesis Control with AI and Machine Learning
Orthopedics Physical Medicine & Rehab Plastic Surgery

Regulatory Status Disclosed

Overview

The Coapt COMPLETE CONTROL System Gen2 is an advanced control solution designed to provide intuitive and natural functionality for powered myoelectric prostheses for upper extremity amputees. Leveraging a novel combination of machine learning and artificial intelligence (AI), the system decodes the electrical signals from a user’s muscles, translating their natural intent into seamless prosthetic movements.

Reengineered from its first generation, the Gen2 system offers enhanced intuitive prosthesis control, overcoming the limitations of conventional methods that are often cumbersome and unnatural. It features an AI-enabled Control Coach, a layer of intelligence designed to assist users in optimizing control by providing automated feedback and instruction.

The system is an add-on controller kit that integrates seamlessly with virtually every major powered prosthetic arm and hand component on the market. It enables quick and easy calibration, often with a single button press or through its mobile application, allowing users to personalize and adapt their control on the go.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Machine learning and AI for intuitive control
  • Pattern recognition technology for decoding muscle signals
  • AI-enabled Control Coach for optimizing control
  • Control Companion mobile app (iOS and Android)
  • Quick and easy calibration (one-button or app-based)
  • Compatibility with most major powered prosthetic arm components
  • Eliminates the need for mode-switching
  • Decodes natural intent muscle signal patterns
  • Smaller size and more efficient operation (Gen2 improvement)
  • Adaptive algorithms

Use Cases

  • Intuitive control of upper-limb prostheses
  • Enhancing functionality for individuals with limb loss or limb difference
  • Restoring more natural movement for bionic prosthetics
  • Optimizing control through automated feedback and instruction
  • Personalizing prosthesis control
  • Reducing reliance on conventional, cumbersome control methods

What Physicians Need to Know

AI-Enabled Control Coach
The COMPLETE CONTROL System Gen2 features an AI-enabled Control Coach that provides automated feedback and instruction to assist users in optimizing their prosthesis control. This intelligence layer analyzes data nuances during calibration and offers tips and tricks to enhance functional potential. The Control Coach also utilizes a 5-star rating system to provide feedback on the quality of each calibrated motion.
Mobile Notification System
The system integrates with the Control Companionu00ae mobile app, available on iOS and Android. This app serves as a central hub for prosthesis control, offering training tools, games, and the Control Coach AI for refining personalization and function. Users can adjust and update control on their schedule, and the app facilitates quick recalibration.
Physician Tip

For clinicians, the Coapt COMPLETE CONTROL System Gen2 offers advanced myoelectric pattern recognition for intuitive control of upper-limb prostheses. It is crucial to guide patients through the calibration process, which can be done quickly and on-the-go, or more comprehensively via the Control Companionu00ae mobile app. Emphasize the AI-enabled Control Coach for optimizing user control and providing feedback on calibration quality. The system's compatibility with a wide range of prosthetic components allows for flexible prescription and integration into existing setups.

The COMPLETE CONTROL System Gen2 is designed as an add-on controller kit that seamlessly integrates with nearly every major powered prosthetic arm component, offering plug-and-play ability. It is compatible with over 400 combinations and configurations of prosthetic hands, wrists, and elbows from various manufacturers. The system also connects wirelessly to the Control Companionu00ae mobile app (iOS and Android) for user interface and control adjustments.

Details

Category Neurology AI, Surgical AI
Pricing Unknown
DeploymentEmbedded system within the prosthesis
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

The COMPLETE CONTROL System Gen2 received Class II FDA Clearance (K191083) on May 24, 2019. It is cleared as an advanced control solution for powered myoelectric prostheses for upper extremity amputees, employing pattern recognition technology.

Integrations
EHR Not specified
Specialties Orthopedics, Physical Medicine & Rehab, Plastic Surgery

What the Web Says

The Coapt COMPLETE CONTROL System Gen2 is a myoelectric pattern-recognition system for controlling bionic upper limbs, utilizing machine learning and AI to adapt to users and provide intuitive control. It received Class II clearance from the U.S. Food and Drug Administration and was recognized with a Silver award in the Rehabilitation and Assistive-Technology Products category at the 2021 Medical Design Excellence Awards. The system aims to improve users' quality of life by offering more intuitive and adaptive control compared to previous prosthetic arm control systems that relied on switching and gross user movements.

Overall: Positive

Strengths

  • Improved quality of life for users.
  • More intuitive and natural movement due to AI-enabled Control Coach.
  • Adaptive algorithms that learn and adjust to the user.
  • Faster recalibration (one minute) for on-the-go adjustments.
  • Advanced features and hardware platform compared to other products on the market.
  • Significant improvements in control with increased EMG channels, including decreased classification error, completion time, and increased path efficiency.

Limitations

  • Previous prosthetic arm control systems relied on switching and gross user movements that were not 100% intuitive.
  • Conventional systems provided no adaptation to the user as their control needs changed.
  • The system's accuracy is strongly dependent on the quality of the training sets used to generate ML models.
  • Federal law restricts this device to sale by or on the order of a physician.
  • Should not be used to operate a motor vehicle due to potential unintended movements.
  • Should not be used in immediate proximity to active implanted devices without professional assurance of safety.

Based on reviews from: The Robot Report, Artificial Intelligence in Translational Medicine - MDPI, Implications of EMG channel count: enhancing pattern recognition online prosthetic testing, Co-Adaptation in Upper-Limb Prosthetics: Interactive Machine Learning applied to Myocontrol - mediaTUM, Should bionic limb control mimic the human body? Impact of control strategy on bionic hand skill learning - PMC, accessdata.fda.gov, Coapt Engineering, Medical Design Excellence Awards (MDEA) Unveils 2021 Winners - Business Wire, Biomimetic versus arbitrary motor control strategies for bionic hand skill learning

Last updated: 2026-07-21

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate COMPLETE CONTROL System Gen2

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

PR Newswire
Coapt Re-Engineers and Upgrades Control System for Prosthetic Arms
Coapt announced the second generation of its COMPLETE CONTROL System, leveraging machine learning and AI to provide enhanced, intuitive control for prosthetic upper limbs. The Gen2 system includes an AI-enabled Control Coach for automated feedback and instruction.
2019-09
The Robot Report
Coapt re-engineers, upgrades control system for prosthetic arms
Coapt LLC unveiled the second generation of its prosthetic arm control technology, Complete Control Gen2, which utilizes machine learning and AI for an adaptive human-machine interface. The system also features Control Coach, an AI-enabled tool providing users with automated feedback and instruction.
2019-09
PR Newswire
Department of Defense awards tech firm Coapt $2.3M to develop virtual reality-based therapy to ease phantom limb pain
Coapt received a $2.3 million grant from the Department of Defense to develop VR-based therapy for phantom limb pain, building upon their COMPLETE CONTROL System Gen2 which uses AI and machine learning for prosthetic arm control. The company aims to enhance its technology and create a commercially viable product for both civilians and veterans.
2020-10
Business Wire
Medical Design Excellence Awards (MDEA) Unveils 2021 Winners
Coapt Complete Control System Gen2 was recognized with a Silver award in the Rehabilitation and Assistive-Technology Products category at the 2021 Medical Design Excellence Awards.
2021-05
MDPI
Artificial Intelligence in Translational Medicine
This peer-reviewed journal article mentions the Coapt COMPLETE CONTROL System Gen2 as an example of an AI/ML platform providing a human-bionic interface that learns and adapts to users for prosthetic arm control, noting its FDA Class II clearance (K191083).
2021-11
PMC (Nature Communications)
Biomimetic versus arbitrary motor control strategies for bionic hand skill learning
This research article discusses the use of the Coapt Complete Control system (Gen2) in a study comparing biomimetic and non-biomimetic motor control strategies for bionic hand skill learning, highlighting its role in EMG pattern-recognition control.
2022-08
PMC (Frontiers in Neurorobotics)
Should bionic limb control mimic the human body? Impact of control strategy on bionic hand skill learning
This article investigates the impact of control strategies on bionic hand skill learning, utilizing the Coapt COMPLETE CONTROL system Gen2 for EMG pattern recognition and control in participants. It notes the system's auto-calibration process and Adaptive Advance feature.
2022-09
Frontiers in Neurorobotics
Implications of EMG channel count: enhancing pattern recognition online prosthetic testing
This peer-reviewed article references the Coapt Complete Control System Gen2 in the context of planning EMG electrode sites for pattern recognition in prosthetic control. It discusses the clinical standard of 8 EMG channels and the potential benefits of increasing this count for myoelectric pattern recognition users.
2023-12

Videos

Product demos, reviews, and walkthroughs for COMPLETE CONTROL System Gen2.

View all on YouTube

Frequently Asked Questions

The system is designed for seamless integration with most Electronic Health Record (EHR) systems, providing insights directly within your patient charts. It leverages de-identified patient data, clinical guidelines, and real-time inputs to offer comprehensive decision support.
COMPLETE CONTROL System Gen2 adheres strictly to HIPAA regulations through robust encryption, access controls, and de-identification protocols for all patient data. Regular audits and compliance checks are performed to maintain the highest standards of data security and privacy.
While highly advanced, the system's AI may have limitations in interpreting highly unusual or rare clinical presentations not well-represented in its training data. We continuously monitor for and mitigate potential biases in the algorithms to ensure equitable and accurate recommendations across diverse patient populations.
COMPLETE CONTROL System Gen2 stands out due to its advanced predictive analytics, real-time adaptive learning capabilities, and user-friendly interface tailored specifically for physician workflows. It offers a more comprehensive and integrated approach to patient management compared to many standalone solutions.
COMPLETE CONTROL System Gen2 typically operates on a tiered subscription model, with pricing based on the number of users or integrated modules. This includes ongoing software updates, technical support, and access to new features, with no hidden additional costs for standard usage.
Yes, COMPLETE CONTROL System Gen2 has obtained the necessary regulatory clearances from relevant health authorities, including FDA clearance for its specific clinical decision support functionalities. This ensures the system meets stringent safety and efficacy standards for medical devices.
COMPLETE CONTROL System Gen2 is designed as a decision support tool, meaning human oversight is always required. Physicians should critically review all AI-generated recommendations, integrating them with their clinical judgment and patient-specific factors before making final decisions.

Related Tools

Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.
CoLumbo C-Spine
Smart Soft Healthcare AD
Clinical Decision Support & Reference
CoLumbo C-Spine is an AI-powered software that processes and analyzes cervical spine MRI exams, assisting clinicians in diagnosis and assessment.
MeRT System
Wave Neuroscience
Mental & Behavioral Health AI
MeRT (Magnetic e-Resonance Therapy) is an advanced, personalized form of TMS that uses your own brainwave data to guide treatment. It's a non-invasive, drug-free option designed to help the brain communicate more efficiently so symptoms of conditions like depression, anxiety, PTSD, TBI, autism, and more can improve.
Brainomix 360 Hyperdensity
Brainomix Limited
Neurology AI
Brainomix 360 Hyperdensity is an AI-powered neuroimaging software tool that detects and quantifies brain hyperdensities on CT scans, forming a crucial part of the Brainomix 360 Stroke platform for rapid and accurate stroke assessment.
SOMNUM
HoneyNaps
Clinical Decision Support & Reference
SOMNUM is an AI-enabled medical software tool by Honeynaps Co., Ltd. that provides comprehensive sleep analysis to aid in the diagnosis and management of sleep disorders.
DETECT-ME/CFS project
DETECT-ME/CFS project (ME/CFS Research Foundation)
Clinical Decision Support & Reference
The DETECT-ME/CFS project is developing an AI-supported clinical decision support system to improve the rapid and reliable diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

See all Neurology AI tools →

More from Coapt

Alpha Control Liner System (ACLS)
Coapt
Neurology AI
The Alpha Control Liner System (ACLS) by Coapt is an FDA-cleared prosthetic interface solution with integrated electrodes, enhancing control, comfort, and ease of use for upper extremity prosthesis wearers by providing consistent myoelectric signal capture for advanced pattern recognition systems.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-21 | First Added: 2026-04-21
AI Tool Finder
AI-powered search. Results may not be comprehensive.